A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice

Clinical trial NCT02320773 · COMPLETED

Trial details

NCT number: NCT02320773
Sponsor: Astellas Pharma Europe Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Urgency Incontinence Urinary Bladder Overactive Overactive Bladder Urologic Diseases Urinary Bladder Diseases

Start date: 2014-11-25
Primary completion: 2016-07-27
Enrollment: 863

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.